Variant report

Variant	esv3323084
Chromosome Location	chr6:11535666-11540364
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:11536592-11537409	HepG2	liver:	n/a	n/a
2	ARID3A	chr6:11535866-11536376	HepG2	liver:	n/a	n/a
3	ATF1	chr6:11537586-11537900	K562	blood:	n/a	n/a
4	ATF2	chr6:11537318-11537972	GM12878	blood:	n/a	n/a
5	ATF3	chr6:11537657-11537976	K562	blood:	n/a	chr6:11537718-11537731
6	ATF3	chr6:11535930-11536315	K562	blood:	n/a	n/a
7	BACH1	chr6:11537743-11537851	K562	blood:	n/a	n/a
8	BACH1	chr6:11537282-11538877	H1-hESC	embryonic stem cell:	n/a	n/a
9	BCLAF1	chr6:11537432-11538165	GM12878	blood:	n/a	chr6:11537877-11537890 chr6:11537959-11537972 chr6:11537953-11537966 chr6:11537739-11537748 chr6:11537842-11537855 chr6:11537524-11537537
10	BCLAF1	chr6:11537620-11538074	GM12878	blood:	n/a	chr6:11537877-11537890 chr6:11537959-11537972 chr6:11537953-11537966 chr6:11537739-11537748 chr6:11537842-11537855
11	BHLHE40	chr6:11538734-11538758	GM12878	blood:	n/a	n/a
12	BHLHE40	chr6:11535994-11536341	HepG2	liver:	n/a	n/a
13	BHLHE40	chr6:11537684-11538283	HepG2	liver:	n/a	chr6:11538021-11538037 chr6:11537950-11537966 chr6:11538081-11538097 chr6:11538013-11538029
14	BHLHE40	chr6:11536004-11536268	K562	blood:	n/a	n/a
15	BHLHE40	chr6:11537681-11538224	K562	blood:	n/a	chr6:11538021-11538037 chr6:11537950-11537966 chr6:11538081-11538097 chr6:11538013-11538029
16	BHLHE40	chr6:11537389-11538214	GM12878	blood:	n/a	chr6:11538021-11538037 chr6:11537950-11537966 chr6:11538081-11538097 chr6:11538013-11538029
17	BRCA1	chr6:11537690-11537814	Hela-S3	cervix:	n/a	n/a
18	BRCA1	chr6:11538066-11538126	GM12878	blood:	n/a	n/a
19	BRCA1	chr6:11538904-11538986	H1-hESC	embryonic stem cell:	n/a	n/a
20	BRCA1	chr6:11537719-11537811	HepG2	liver:	n/a	n/a
21	CBX3	chr6:11537582-11537948	K562	blood:	n/a	n/a
22	CCNT2	chr6:11537429-11538528	K562	blood:	n/a	chr6:11538255-11538264 chr6:11537651-11537660
23	CEBPB	chr6:11536071-11536351	Hela-S3	cervix:	n/a	chr6:11536324-11536335
24	CEBPB	chr6:11537493-11538134	HepG2	liver:	n/a	n/a
25	CEBPB	chr6:11539807-11539974	HepG2	liver:	n/a	chr6:11539818-11539829
26	CEBPD	chr6:11538775-11539029	HepG2	liver:	n/a	n/a
27	CEBPD	chr6:11537430-11538071	HepG2	liver:	n/a	n/a
28	CHD1	chr6:11538020-11538338	GM12878	blood:	n/a	n/a
29	CHD2	chr6:11537542-11538221	Hela-S3	cervix:	n/a	n/a
30	CHD2	chr6:11537549-11538156	GM12878	blood:	n/a	n/a
31	CHD2	chr6:11537603-11538243	HepG2	liver:	n/a	n/a
32	CHD2	chr6:11537722-11537833	K562	blood:	n/a	n/a
33	CHD2	chr6:11537457-11537907	H1-hESC	embryonic stem cell:	n/a	n/a
34	CHD2	chr6:11538576-11539108	GM12878	blood:	n/a	chr6:11538686-11538696 chr6:11538785-11538795
35	CREB1	chr6:11537526-11538040	H1-hESC	embryonic stem cell:	n/a	n/a
36	CREB1	chr6:11537088-11538449	HepG2	liver:	n/a	n/a
37	CREB1	chr6:11537356-11538201	HepG2	liver:	n/a	n/a
38	CREB1	chr6:11537569-11537997	ECC-1	luminal epithelium:	n/a	n/a
39	CREB1	chr6:11537441-11538244	GM12878	blood:	n/a	n/a
40	CREB1	chr6:11537513-11537976	H1-hESC	embryonic stem cell:	n/a	n/a
41	CREB1	chr6:11537596-11537868	A549	lung:	n/a	n/a
42	CREB1	chr6:11537442-11538091	A549	lung:	n/a	n/a
43	CREB1	chr6:11537513-11538005	ECC-1	luminal epithelium:	n/a	n/a
44	CREB1	chr6:11537405-11538115	K562	blood:	n/a	n/a
45	CREB1	chr6:11537427-11538110	K562	blood:	n/a	n/a
46	CTBP2	chr6:11537146-11538336	H1-hESC	embryonic stem cell:	n/a	n/a
47	CTCF	chr6:11538100-11538250	GM12870	blood:	n/a	n/a
48	CTCF	chr6:11538124-11538194	GM10248	blood:	n/a	n/a
49	CTCF	chr6:11538133-11538171	MCF-7	breast:	n/a	n/a
50	CTCF	chr6:11537340-11537490	GM12866	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:11537706-11537756	HCF	heart:	n/a
2	chr6:11537706-11537756	HCF	heart:	n/a
3	chr6:11538528-11538578	K562	blood:	n/a
4	chr6:11537706-11537756	AG04449	skin:	fetal
5	chr6:11538767-11538817	GM12891	blood:	n/a
6	chr6:11537229-11537279	GM19239	blood:	n/a
7	chr6:11539786-11539836	MCF-7	breast:	n/a
8	chr6:11538767-11538817	HRCEpiC	kidney:	n/a
9	chr6:11538014-11538064	NHBE	bronchial:	n/a
10	chr6:11537185-11537235	RPTEC	kidney:	n/a
11	chr6:11537185-11537235	SAEC	small airway:	n/a
12	chr6:11537185-11537235	BE2_C	brain:	n/a
13	chr6:11537105-11537155	Hepatocyte	liver:	n/a
14	chr6:11538767-11538817	SAEC	small airway:	n/a
15	chr6:11538582-11538632	Caco-2	colon:	n/a
16	chr6:11537706-11537756	ECC-1	luminal epithelium:	n/a
17	chr6:11538528-11538578	PANC-1	pancreas:	n/a
18	chr6:11537861-11537911	AG09309	skin:	n/a
19	chr6:11538582-11538632	SAEC	small airway:	n/a
20	chr6:11537105-11537155	SK-N-SH	brain:	n/a
21	chr6:11537229-11537279	SAEC	small airway:	n/a
22	chr6:11537861-11537911	GM12891	blood:	n/a
23	chr6:11538071-11538121	HRE	kidney:	n/a
24	chr6:11537861-11537911	Jurkat	blood:	n/a
25	chr6:11538582-11538632	HCPEpiC	choroid plexus:	n/a
26	chr6:11538646-11538696	HL-60	blood:	n/a
27	chr6:11537229-11537279	AG04450	lung:	fetal
28	chr6:11537229-11537279	A549	lung:	n/a
29	chr6:11538646-11538696	NHDF-neo	bronchial:	n/a
30	chr6:11538582-11538632	IMR90	lung:	fetal
31	chr6:11537706-11537756	HIPEpiC	eye:	n/a
32	chr6:11537229-11537279	HEEpiC	esophagus:	n/a
33	chr6:11538646-11538696	HIPEpiC	eye:	n/a
34	chr6:11538646-11538696	GM12891	blood:	n/a
35	chr6:11537185-11537235	NB4	blood:	n/a
36	chr6:11539786-11539836	T-47D	breast:	n/a
37	chr6:11538582-11538632	ProgFib	skin:	n/a
38	chr6:11537105-11537155	PANC-1	pancreas:	n/a
39	chr6:11538071-11538121	HRPEpiC	eye:	n/a
40	chr6:11538767-11538817	NHBE	bronchial:	n/a
41	chr6:11537185-11537235	HNPCEpiC	eye:	n/a
42	chr6:11538014-11538064	NB4	blood:	n/a
43	chr6:11537861-11537911	HUVEC	blood vessel:	n/a
44	chr6:11537185-11537235	SK-N-MC	brain:	n/a
45	chr6:11537706-11537756	Jurkat	blood:	n/a
46	chr6:11537105-11537155	Jurkat	blood:	n/a
47	chr6:11537105-11537155	GM19239	blood:	n/a
48	chr6:11537185-11537235	Jurkat	blood:	n/a
49	chr6:11538582-11538632	Hela-S3	cervix:	n/a
50	chr6:11538582-11538632	HEEpiC	esophagus:	n/a

No.	Distal block	Cell Line	Cell type
1	chr19:47291454..47293291-chr6:11538059..11540323,2	MCF-7	breast:
2	chr6:11539069..11540912-chr6:11545787..11548453,2	K562	blood:
3	chr6:11537155..11540056-chr6:11540130..11543939,4	MCF-7	breast:
4	chr6:11044361..11045128-chr6:11537353..11538230,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TMEM170B-3	chr6:11537520-11537764	l_3112_chr6:11525493-11597341_testes

Variant related genes	Relation type
TMEM170B	TF binding region
TMEM170B	CpG island
ENSG00000205269	chromatin interactions
ENSG00000230314	chromatin interactions
ENSG00000197977	chromatin interactions
ENSG00000105281	chromatin interactions

Extended variants
information (count: 148 )
Associated
traits (count: 98 )

Variant overlapped rSNPs/rCNVs (count:148 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs182519000	chr6:11535717-11535718	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs187166641	chr6:11535783-11535784	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs536346451	chr6:11535843-11535844	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs576805978	chr6:11535844-11535845	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs545840428	chr6:11535874-11535875	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs141751847	chr6:11535878-11535879	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs57324707	chr6:11535933-11535934	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs567214590	chr6:11535961-11535962	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs541979425	chr6:11536021-11536022	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs200346417	chr6:11536055-11536056	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs562273333	chr6:11536109-11536110	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs539327146	chr6:11536136-11536137	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs531045012	chr6:11536140-11536141	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs544896852	chr6:11536152-11536153	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs564815737	chr6:11536221-11536222	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs532132996	chr6:11536235-11536236	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs569848148	chr6:11536311-11536312	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs565546511	chr6:11536410-11536411	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs528164821	chr6:11536427-11536428	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs547998386	chr6:11536448-11536449	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs557958317	chr6:11536720-11536721	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs568232002	chr6:11536721-11536722	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs376415710	chr6:11536764-11536765	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs192822963	chr6:11536770-11536771	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs544770901	chr6:11536842-11536843	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs570453938	chr6:11536857-11536858	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs559172635	chr6:11536912-11536913	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs185308729	chr6:11536917-11536918	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs77841729	chr6:11536945-11536946	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs28618679	chr6:11537004-11537005	Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs12190822	chr6:11537014-11537015	Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs137914232	chr6:11537017-11537018	Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs57366800	chr6:11537020-11537021	Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs57173268	chr6:11537030-11537031	Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs535927546	chr6:11537049-11537050	Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs193271010	chr6:11537070-11537071	Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs370898261	chr6:11537090-11537091	Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs142946431	chr6:11537091-11537092	Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs74976110	chr6:11537106-11537107	Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
40	rs564676744	chr6:11537152-11537153	Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
41	rs76112391	chr6:11537186-11537187	Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
42	rs540951418	chr6:11537302-11537303	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs559268713	chr6:11537320-11537321	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs528110656	chr6:11537360-11537361	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs72834795	chr6:11537368-11537369	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs661055	chr6:11537376-11537377	Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
47	rs530611065	chr6:11537492-11537493	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs550321209	chr6:11537539-11537540	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
49	rs570333809	chr6:11537566-11537567	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
50	rs539313427	chr6:11537569-11537570	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:98)

Disease	PMID	Source
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Cancer	20164920	CNVD
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Multiple myeloma	17550852	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
small cell lung cancer	20016488	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Osteosarcoma	16790693	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Ovarian cancer	21720365	CNVD
Melanoma	20688739	CNVD
Cancer	21183584	CNVD
Acute myeloid leukemia	18000384	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21364760	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Bladder cancer	21909424	CNVD
Myelofibrosis	22110671	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Burkitt''s lymphoma	19759907	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD

Chromatin state (count:489 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:11522000-11536400	Weak transcription	Pancreatic Islets	Pancreatic Islet
2	chr6:11527000-11537000	Weak transcription	Placenta	Placenta
3	chr6:11527400-11537200	Weak transcription	Gastric	stomach
4	chr6:11528000-11536800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
5	chr6:11531200-11536800	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
6	chr6:11531400-11536200	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
7	chr6:11531400-11536200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
8	chr6:11531800-11536000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
9	chr6:11531800-11537400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
10	chr6:11532000-11535800	Weak transcription	Primary monocytes fromperipheralblood	blood
11	chr6:11532000-11536000	Weak transcription	Primary hematopoietic stem cells short term culture	blood
12	chr6:11532400-11536200	Weak transcription	Rectal Smooth Muscle	rectum
13	chr6:11533000-11537000	Weak transcription	Stomach Smooth Muscle	stomach
14	chr6:11534600-11536600	Enhancers	HepG2	liver
15	chr6:11534600-11537000	Enhancers	Liver	Liver
16	chr6:11535000-11535800	Active TSS	Adipose Nuclei	Adipose
17	chr6:11535200-11536800	Enhancers	Primary neutrophils fromperipheralblood	blood
18	chr6:11535400-11537000	Enhancers	HUVEC	blood vessel
19	chr6:11535600-11536000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
20	chr6:11535600-11536000	Enhancers	Monocytes-CD14+_RO01746	blood
21	chr6:11535600-11537000	Enhancers	Hela-S3	cervix
22	chr6:11535800-11536000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
23	chr6:11535800-11536000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
24	chr6:11535800-11536000	Flanking Active TSS	Adipose Nuclei	Adipose
25	chr6:11535800-11536000	Enhancers	Small Intestine	intestine
26	chr6:11535800-11536000	Enhancers	NH-A	brain
27	chr6:11535800-11536200	Enhancers	Fetal Intestine Large	intestine
28	chr6:11535800-11536600	Enhancers	HMEC	breast
29	chr6:11535800-11536800	Enhancers	Primary monocytes fromperipheralblood	blood
30	chr6:11535800-11536800	Enhancers	Brain Hippocampus Middle	brain
31	chr6:11535800-11537000	Enhancers	Breast Myoepithelial Primary Cells	Breast
32	chr6:11536000-11536400	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
33	chr6:11536000-11536800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
34	chr6:11536000-11536800	Enhancers	Primary hematopoietic stem cells short term culture	blood
35	chr6:11536000-11537000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
36	chr6:11536000-11537000	Enhancers	Adipose Nuclei	Adipose
37	chr6:11536000-11537000	Enhancers	Brain Anterior Caudate	brain
38	chr6:11536000-11537000	Weak transcription	NH-A	brain
39	chr6:11536000-11537400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
40	chr6:11536200-11536400	Enhancers	Brain Angular Gyrus	brain
41	chr6:11536200-11536400	Enhancers	Brain Cingulate Gyrus	brain
42	chr6:11536200-11536400	Enhancers	Brain Inferior Temporal Lobe	brain
43	chr6:11536200-11536600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
44	chr6:11536200-11536600	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
45	chr6:11536200-11536600	Weak transcription	Fetal Intestine Large	intestine
46	chr6:11536200-11536800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
47	chr6:11536200-11536800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
48	chr6:11536200-11536800	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
49	chr6:11536200-11536800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
50	chr6:11536200-11536800	Enhancers	Primary B cells from cord blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links